Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome
Abstract Background Postprandial hyperglycemia was reported to play a key role in established risk factors of coronary artery diseases (CAD) and cardiovascular events. Serum 1,5-anhydroglucitol (1,5-AG) levels are known to be a clinical marker of short-term postprandial glucose (PPG) excursions. Low...
Main Authors: | Gong Su, Ming-Xi Gao, Gen-Ling Shi, Xi-Xi Dai, Wei-Feng Yao, Tao Zhang, Shao-Wei Zhuang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-020-01045-0 |
Similar Items
-
Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes
by: Ha Yeong Yoo, et al.
Published: (2015-12-01) -
The marker of adverse prognosis 1.5-anhydroglucitol in patients with coronary heart disease in the long-term period after planned myocardial revascularization
by: Yu S Ignatova, et al.
Published: (2019-04-01) -
Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
by: John Peabody, et al.
Published: (2020-06-01) -
Optical coherence tomography evaluating the culprit coronary lesion
by: Jin-Chuan Yan, et al.
Published: (2016-01-01) -
Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
by: Ji-Eun Lee
Published: (2015-06-01)